Nanovector approach for co-delivery of Alectinib and Hesperidin via inhalational for lung cancer treatment: development, characterization, and preclinical studies
The prepared ALB-HSD NLC could be promising drug carriers, and they succeeded in delivering small and efficient doses of ALB and HSD to treat NSCLC.
Authors
- Anjali Rathee
- Jayamanti Pandit
- Shahnaj Bano
- Nasr A. Emad
- Yasmin Sultana (ORCID: https://orcid.org/0000-0002-3979-6574)
- Saeem Ahmad (ORCID: https://orcid.org/0000-0002-0519-6693)
- Mohd. Aqil (ORCID: https://orcid.org/0000-0001-6797-3104)
- Iqra Zai (ORCID: https://orcid.org/0000-0001-7790-2182)
- Shadab Alam
Institutions
- Jamia Hamdard (IN)
Publication Details
- Journal
- Expert Opinion on Drug Delivery
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1080/17425247.2025.2487585
- Citations
- 2
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Indian Council of Medical Research